Nivolumab ELISA (mAb-based)
Enzyme immunoassay for the specific and quantitative determination of free Nivolumab (Opdivo®) in serum and plasma.
The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Nivolumab. Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.
Reference: IG-AB113
Barcode: 8682754930318
Legal Status: CE-Mark
Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Assay Design:
Related Documents
Instructions for Use IG-AB113 692.27 KB
Material Safety Data Sheet (MSDS) IG-AB113 268.20 KB
Opdivo® is a trademark of Bristol-Myers Squibb Company.
The Kit at a glance:
| Required Volume (µL) | 10 |
| Incubation Time (min) | 105 |
| Sample | Serum or Plasma |
| Package Size | 96 Tests |
| Standard Range (ng/mL, 10x) | 0-6000 |
| Detection Limit (ng/mL) | 15 |
| Spike Recovery (%) | >95 |
| Shelf Life (years) | 2 |
Standard Curve:
